| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.98▼ | 2.15▼ | 2.15▼ | 2.14▼ | 1.92▲ |
| MA10 | 2.09▼ | 2.17▼ | 2.20▼ | 1.91▲ | 2.12▼ |
| MA20 | 2.14▼ | 2.20▼ | 2.17▼ | 1.82▲ | 2.51▼ |
| MA50 | 2.18▼ | 2.16▼ | 2.03▼ | 2.12▼ | 5.91▼ |
| MA100 | 2.17▼ | 1.96▲ | 1.84▲ | 2.54▼ | 11.25▼ |
| MA200 | 2.05▼ | 1.92▲ | 2.06▼ | 5.85▼ | 20.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.031▼ | -0.022▼ | -0.027▼ | 0.076▲ | 0.157▲ |
| RSI | 29.825▼ | 32.792▼ | 37.801▼ | 49.194▼ | 30.023▼ |
| STOCH | 31.113 | 21.294 | 26.118 | 76.617 | 24.788 |
| WILL %R | -67.123 | -79.661▼ | -79.661▼ | -52.083 | -72.121 |
| CCI | -105.328▼ | -250.526▼ | -208.351▼ | 51.480 | -54.548 |
|
Tuesday, April 14, 2026 12:04 PM
Let’s dig into the relative performance of Toast (NYSE:TOST) and its peers as we unravel the now-completed Q4 vertical software earnings season.
|
|
Tuesday, April 14, 2026 05:10 AM
Adds dedicated business development leadership to support Tempest’s strategic prioritiesWill lead China outreach and cross-border partnership effortsTo support ongoing partnering discussions for Phase ...
|
|
Wednesday, April 08, 2026 01:07 AM
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/04/26 | 2.24 | 2.2745 | 1.80 | 1.96 | 496,118 |
| 16/04/26 | 2.12 | 2.46 | 2.02 | 2.24 | 503,225 |
| 15/04/26 | 2.25 | 2.25 | 2.10 | 2.12 | 171,136 |
| 14/04/26 | 2.21 | 2.27 | 2.05 | 2.25 | 313,150 |
| 13/04/26 | 2.08 | 2.30 | 2.01 | 2.14 | 565,152 |
| 10/04/26 | 1.63 | 2.15 | 1.59 | 2.05 | 1,694,197 |
| 09/04/26 | 1.56 | 1.63 | 1.55 | 1.58 | 111,100 |
| 08/04/26 | 1.60 | 1.605 | 1.54 | 1.56 | 151,298 |
| 07/04/26 | 1.55 | 1.58 | 1.5101 | 1.56 | 54,151 |
| 06/04/26 | 1.61 | 1.655 | 1.55 | 1.59 | 179,132 |
|
|
||||
|
|
||||
|
|